RXi Pharmaceuticals last week announced that its stock has begun trading on the OTCQX stock exchange.
According to the company, this over-the-counter exchange is reserved for “high-quality U.S. companies that meet financial standards, undergo management reviews and provide timely news and disclosure to investors.”
RXi had at one time traded on the Nasdaq, but lost its listing when it merged with Apthera in 2011. The new company changed its name to Galena, took RXi’s stock listing, and made RXi a subsidiary. RXi was later spun out as a publicly traded independent company again, but traded on the over-the-counter bulletin board (GSN 4/26/2012).